Fig. 2.
Cumulative incidences of adverse endpoints. Comparison between patients with HFrEF and matched controls without HF. A) Time to CV death or HF admission. B) Time to CV death. C) Time to HF admission. D) Time to all-cause death. E) Time to non-HF admission. AR: absolute risk; RD: risk difference; RR: relative risk.
